Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo

BACKGROUND: Development of chemo−/radioresistance is a major challenge for the current prostate cancer (CaP) therapy. We have previously demonstrated that epithelial cell adhesion molecule (EpCAM) is associated with CaP growth and therapeutic resistance in vitro, however, the role of EpCAM in CaP in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Jie, Cozzi, Paul, Beretov, Julia, Duan, Wei, Bucci, Joseph, Graham, Peter, Li, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233586/
https://www.ncbi.nlm.nih.gov/pubmed/30419852
http://dx.doi.org/10.1186/s12885-018-5010-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233586/
https://www.ncbi.nlm.nih.gov/pubmed/30419852
http://dx.doi.org/10.1186/s12885-018-5010-5

Ejemplares similares